541 related articles for article (PubMed ID: 12861075)
21. Transforming growth factor-beta in cutaneous melanoma.
Javelaud D; Alexaki VI; Mauviel A
Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
[TBL] [Abstract][Full Text] [Related]
22. [TGF-beta signaling during bone metastasis of breast cancer and in-vivo imaging].
Imamura T; Hanyu A
Clin Calcium; 2008 Apr; 18(4):460-5. PubMed ID: 18379027
[TBL] [Abstract][Full Text] [Related]
23. [When the curtain goes up on spinophilin's tumor suppressor function].
Sarrouilhe D; Ladeveze V
Med Sci (Paris); 2012 Jan; 28(1):26-8. PubMed ID: 22289823
[No Abstract] [Full Text] [Related]
24. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
25. beta-tting on p63 as a metastatic suppressor.
Clohessy JG; Pandolfi PP
Cell; 2009 Apr; 137(1):28-30. PubMed ID: 19345184
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
27. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
28. Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
Urtreger AJ; Werbajh SE; Verrecchia F; Mauviel A; Puricelli LI; Kornblihtt AR; Bal de Kier Joffé ED
Oncol Rep; 2006 Dec; 16(6):1403-10. PubMed ID: 17089068
[TBL] [Abstract][Full Text] [Related]
29. Blockade of the TGF-beta superfamily by Smad7: breaking a link in the metastatic chain.
Fidler IJ
J Natl Cancer Inst; 2005 Dec; 97(23):1714-5. PubMed ID: 16333022
[No Abstract] [Full Text] [Related]
30. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
31. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta and cancer.
Bierie B; Moses HL
Cytokine Growth Factor Rev; 2006; 17(1-2):29-40. PubMed ID: 16289860
[TBL] [Abstract][Full Text] [Related]
33. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
[TBL] [Abstract][Full Text] [Related]
34. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
35. Role of transforming growth factor beta in human disease.
Blobe GC; Schiemann WP; Lodish HF
N Engl J Med; 2000 May; 342(18):1350-8. PubMed ID: 10793168
[No Abstract] [Full Text] [Related]
36. Transforming growth factor-beta: what every pancreatic surgeon should know.
Truty MJ; Urrutia R
Surgery; 2007 Jan; 141(1):1-6. PubMed ID: 17188161
[No Abstract] [Full Text] [Related]
37. TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy.
Yang L
Curr Mol Med; 2010 Jun; 10(4):374-80. PubMed ID: 20455854
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of carcinogenesis and biologically based models for estimation and prediction of risk.
Moolgavkar S; Krewski D; Schwarz M
IARC Sci Publ; 1999; (131):179-237. PubMed ID: 10505297
[No Abstract] [Full Text] [Related]
39. [Deregulated expression of homeobox genes and cancer metastasis].
Hamada J; Moriuchi T
Nihon Rinsho; 2002 May; 60 Suppl 5():110-5. PubMed ID: 12101638
[No Abstract] [Full Text] [Related]
40. [Oncogenes and anti-oncogenes in carcinogenesis].
Sugimura T
Nihon Rinsho; 1990 Aug; 48(8):5-7. PubMed ID: 2255095
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
